CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(01): 59-61
DOI: 10.4103/0971-5851.203503
Case Report

Pheochromocytoma in a Child without Hypertension: A Contribution to the “Rule of 10s”

Prasanta Kumar Tripathy
Department of Pediatric Surgery, SCB Medical College, Cuttack, Odisha, India
,
Kaumudee Pattnaik
Department of Pathology, SCB Medical College, Cuttack, Odisha, India
,
Manjushree Nayak
Department of Pathology, SCB Medical College, Cuttack, Odisha, India
,
Hiranya Kishor Mohanty
Department of Pediatric Surgery, SCB Medical College, Cuttack, Odisha, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Pheochromocytoma (PCC) is a neuroendocrine tumor originating from chromaffin tissue in adrenal medulla. Its diagnosis and treatment are well defined in adults, but experience in children is limited. Children constitute only 10% of reported cases, the average age at presentation being 11 years. The most common presentation is sustained hypertension, which is absent in only 10% of children. We managed a 14-month-old female child with PCC, but she was not hypertensive. We report two unusual features, in this case, an extremely young age at presentation and a childhood case of nonhypertensive PCC contributing for “rule of 10s.”



Publication History

Article published online:
06 July 2021

© 2017. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Eren E, Saglam H, Caliskan Y, Kiristioglu I, Tarim O. Pediatric patients with pheochromocytoma: Experience of a tertiary health center. Pediatr Int 2015;57:875-9.
  • 2 Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, et al. Acurrent review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2010;95:2023-37.
  • 3 Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor. J Surg Oncol 2005;89:193-201.
  • 4 Caty MG, Escobar MA Jr. Adrenal tumors. In: Coran AG, Adzick NS, Krummel TM, Laberge J, Shamberger RC, Caldmone AA, editors. Pediatric Surgery. 7th ed. Philadelphia: Elsevier Saunders; 2012. p. 557-66.
  • 5 Ein SH, Pullerits J, Creighton R, Balfe JW. Pediatric pheochromocytoma. A 36-year review. Pediatr Surg Int 1997;12:595-8.
  • 6 Ciftci AO, Tanyel FC, Senocak ME, Büyükpamukçu N. Pheochromocytoma in children. J Pediatr Surg 2001;36:447-52.
  • 7 Armstrong R, Sridhar M, Greenhalgh KL, Howell L, Jones C, Landes C, et al. Phaeochromocytoma in children. Arch Dis Child 2008;93:899-904.
  • 8 Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-75.
  • 9 Bissada NK, Safwat AS, Seyam RM, Al Sobhi S, Hanash KA, Jackson RJ, et al. Pheochromocytoma in children and adolescents: A clinical spectrum. J Pediatr Surg 2008;43:540-3.
  • 10 Beck O, Fassbender WJ, Beyer P, Kriener S, Neumann HP, Klingebiel T, et al. Pheochromocytoma in childhood: Implication for further diagnostic procedures. Acta Paediatr 2004;93:1630-4.